The mark consists of two lines or bands forming a design resembling a stylized arrow and the word LUPKYNIS in stylized form.
Mark For: LUPKYNIS® trademark registration is intended to cover the categories of
>The mark consists of the stylized wording LUPKYNIS to the top right of two half arrows pointing up. The color gray in the mark represents shading and is not a part of the mark.
Research | OneLook Acronym Finder |
Serial Number | 90306989 |
Registration Number | 6642346 |
Mark Literal Elements | LUPKYNIS |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED 2021-02-24 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Matthew R. Wilmot |
Attorney Docket Number | 66570-28 |
2020-11-09 | Application Filed |
2020-11-12 | Location: NEW APPLICATION PROCESSING |
2020-11-12 | Status: Live/Pending |
2020-11-12 | Transaction Date |
2021-02-24 | Location: LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED |
2021-02-24 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
2022-02-15 | Trademark Registered |
Party: | Aurinia Pharmaceuticals Inc. |
Address | 1203 - 4464 Markham St. Victoria, B.C. CANADA V8Z7X8 |
Legal Entity Type | Company |
Legal Entity State | CANADA |
Application | 2020-11-09 | |
Drawing | 2020-11-09 | |
Design Search Code Corr Project | 2021-01-08 | |
Notation to File | 2021-02-23 | |
Notation to File | 2021-02-24 | |
Notation to File | 2021-02-24 | |
Notation to File | 2021-02-24 | |
Offc Action Outgoing | 2021-02-24 | |
XSearch Search Summary | 2021-02-24 | |
XSearch Search Summary | 2021-02-24 | |
Amendment to Allege Use | 2021-05-12 | |
Specimen | 2021-05-12 | |
AAU Processing Complete | 2021-05-14 | |
Notation to File | 2021-06-21 | |
Offc Action Outgoing | 2021-06-21 | |
Notice of Acceptance of AAU | 2021-06-22 | |
Response to Office Action | 2021-08-20 | |
Specimen | 2021-08-20 | |
Amendment and Mail Process Complete | 2021-08-25 | |
Response to Office Action | 2021-08-30 | |
Amendment and Mail Process Complete | 2021-09-01 | |
Examiners Amendment | 2021-10-21 | |
Amendment and Mail Process Complete | 2021-10-22 | |
TRAM Snapshot of App at Pub for Oppostn | 2021-10-22 | |
Notice of Publication | 2021-11-10 | |
Notification Of Notice of Publication | 2021-11-10 | |
OG Publication Confirmation | 2021-11-30 | |
Registration Certificate | 2022-02-15 |
24.15.10 | Arrows, more than one; More than one arrow |
26.17.06 | Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal |
26.17.12 | Angles (geometric); Chevrons |
241502 | Arrows forming any other geometric figure |
241510 | Arrows, more than one; More than one arrow |
261706 | Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal |
261712 | Angles (geometric); Chevrons |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis. FIRST USE: 20210122. FIRST USE IN COMMERCE: 20210122
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
DM0000 | The mark consists of two lines or bands forming a design resembling a stylized arrow and the word LUPKYNIS in stylized form. |
DM0000 | The mark consists of the stylized wording LUPKYNIS to the top right of two half arrows pointing up. The color gray in the mark represents shading and is not a part of the mark. |
Description | Date | Proceeding Number |
---|---|---|
REGISTERED-PRINCIPAL REGISTER | 2022-02-15 | |
PUBLISHED FOR OPPOSITION | 2021-11-30 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-11-30 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-11-10 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-10-21 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2021-10-21 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2021-10-21 | 74677 |
EXAMINER'S AMENDMENT ENTERED | 2021-10-21 | 88888 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-10-21 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-08-31 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-08-30 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-08-30 | 88889 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-08-24 | 96338 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-08-24 | 96338 |
ASSIGNED TO LIE | 2021-08-24 | 96338 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-08-20 | |
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2021-06-22 | |
USE AMENDMENT ACCEPTED | 2021-06-21 | 74677 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-06-21 | 6325 |
NON-FINAL ACTION WRITTEN | 2021-06-21 | 74677 |
NON-FINAL ACTION E-MAILED | 2021-06-21 | 6325 |
USE AMENDMENT FILED | 2021-05-13 | 88889 |
AMENDMENT TO USE PROCESSING COMPLETE | 2021-05-13 | 88889 |
TEAS AMENDMENT OF USE RECEIVED | 2021-05-12 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-02-24 | 6325 |
NON-FINAL ACTION WRITTEN | 2021-02-24 | 74677 |
NON-FINAL ACTION E-MAILED | 2021-02-24 | 6325 |
ASSIGNED TO EXAMINER | 2021-02-19 | 74677 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2021-01-08 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-01-07 | |
NEW APPLICATION ENTERED IN TRAM | 2020-11-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.